Dr. Vincent Chung, MD
Claim this profileCity of Hope Medical Center
Expert in Pancreatic Cancer
Expert in Stomach Cancer
21 reported clinical trials
33 drugs studied
About Vincent Chung, MD
Education:
- Earned an MD from the University of Tennessee Health Science Center College of Medicine, class of 1998.
Experience:
- Completed an Internship and Residency in Internal Medicine at California Pacific Medical Center.
- Undertook a Fellowship in Hematology and Medical Oncology at Los Angeles County-Harbor-UCLA Medical Center.
- Served as Chief Resident at California Pacific Medical Center.
- Board-certified in Internal Medicine and Medical Oncology.
- Affiliated with City of Hope's Helford Clinical Research Hospital, specializing in Medical Oncology.
Area of expertise
1Pancreatic Cancer
Global LeaderStage IV
ctDNA positive
NRAS positive
2Stomach Cancer
Global LeaderStage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Vincent Chung, MD is currently running
IMM-1-104
for Solid Cancers
This trial is testing a new drug called IMM-1-104 to see if it can help treat advanced cancers with specific genetic changes. The drug works by blocking signals that make cancer cells grow.
Recruiting1 award Phase 1 & 2
Pembrolizumab + Olaparib
for Pancreatic Cancer
This phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline BRCA1 or BRCA2 mutations that has spread to other places in the body (metastatic). BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. These proteins help repair damaged deoxyribonucleic acid (DNA) and, therefore, play a role in ensuring the stability of each cell's genetic material. When either of these genes is mutated, or altered, such that its protein product is not made or does not function correctly, DNA damage may not be repaired properly. As a result, cells are more likely to develop additional genetic alterations that can lead to some types of cancer, including pancreatic cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Olaparib is an inhibitor of PARP, a protein that helps repair damaged DNA. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of pembrolizumab to the usual treatment of olaparib may help to shrink tumors in patients with metastatic pancreatic cancer with BRCA1 or BRCA2 mutations.
Recruiting1 award Phase 237 criteria
More about Vincent Chung, MD
Clinical Trial Related2 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Vincent Chung, MD has experience with
- Pembrolizumab
- Lenvatinib Mesylate
- Gemcitabine Hydrochloride
- Nivolumab
- Ipilimumab
- Gemcitabine
Breakdown of trials Vincent Chung, MD has run
Pancreatic Cancer
Stomach Cancer
Skin Cancer
Uterine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vincent Chung, MD specialize in?
Vincent Chung, MD focuses on Pancreatic Cancer and Stomach Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are ctDNA positive.
Is Vincent Chung, MD currently recruiting for clinical trials?
Yes, Vincent Chung, MD is currently recruiting for 9 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Vincent Chung, MD has studied deeply?
Yes, Vincent Chung, MD has studied treatments such as Pembrolizumab, Lenvatinib Mesylate, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Vincent Chung, MD?
Apply for one of the trials that Vincent Chung, MD is conducting.
What is the office address of Vincent Chung, MD?
The office of Vincent Chung, MD is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.